These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A complementary method for the quantitative evaluation of rat stomach with Shay-ulcer. Ezer E; Szporny L J Pharm Pharmacol; 1975 Nov; 27(11):866-7. PubMed ID: 1499 [No Abstract] [Full Text] [Related]
8. Benzodiazepine-anticholinergic drug interaction: protection against experimental gastric mucosal damage. Fano M; Levi G; Montagna D; Bernareggi V Farmaco Prat; 1982 Jan; 37(1):20-7. PubMed ID: 6120097 [No Abstract] [Full Text] [Related]
9. [The pharmacological blockade of the cardiac and gastric enteric ganglia by a new parasympatholytic]. Remizov IM; Berehova TV; Hroĭsman SD; Kharchenko MM; Purnyn' OE; Skok VI Fiziol Zh (1994); 1999; 45(4):61-8. PubMed ID: 10474804 [TBL] [Abstract][Full Text] [Related]
10. [Gastrozepin--a new anti-ulcer agent (a review of the literature and the authors' own data)]. Grigor'ev IIa; Zhivodereov VM; Khar'kovskiĭ NN Ter Arkh; 1984; 56(2):43-5. PubMed ID: 6369608 [No Abstract] [Full Text] [Related]
11. [Some evaluation of the influence exerted by diverse anticholinergics on the development of experimental destruction of the gastric mucosa in albine rats]. Barnaulov OD; Saveliev AK Farmakol Toksikol; 1971; 34(5):557-60. PubMed ID: 4402765 [No Abstract] [Full Text] [Related]
12. [Findings in the gastric mucosa and gastric secretion in rats treated with methyl O-(4-hydroxy-3-methoxycinnamoyl)reserpate (CD-3400) and reserpine derivatives]. Chiba M; Miyake N; Tamada T; Fujimoto Y; Okabe S Nihon Yakurigaku Zasshi; 1976 Nov; 72(8):969-78. PubMed ID: 14871 [TBL] [Abstract][Full Text] [Related]
13. [Effect of hypothiazide on gastric secretion in peptic ulcer]. Orlikov GA; Makena VD Vrach Delo; 1980 Mar; (3):26-8. PubMed ID: 7376605 [No Abstract] [Full Text] [Related]
14. Anti-ulcer and antisecretory activity of selected imidazopiperidines. Arcari G; Bernardi L; Cimaschi R; Falconi G; Luini F; Scarponi U Arzneimittelforschung; 1984; 34(11):1467-71. PubMed ID: 6543121 [TBL] [Abstract][Full Text] [Related]
15. Pharmacology of zolimidine (2-(p-methylsulfonylphenyl)-imidazo (1,2-a) pyridine) a new non-anticholinergic gastroprotective agent. III). Gastric antisecretory activity, antagonism against acid hypersecretion induced by pentagastrin and histamine, and other effects. Murmann W; Carminati GM; Cattaneo R Panminerva Med; 1974 Oct; 16(10):335-46. PubMed ID: 4155796 [No Abstract] [Full Text] [Related]
16. [The effect of cholinergic-potentiating and cholinergic-blocking agents on reparative processes in the damaged gastric mucosa of rats]. Losev NA; Kuznetsova NN Eksp Klin Farmakol; 1992; 55(5):15-7. PubMed ID: 1305444 [TBL] [Abstract][Full Text] [Related]
17. [Stomach diseases. Pathogenesis and therapeutic aspects with special regard to therapy with Sucsan-Azulen comp]. Trentmann M Fortschr Med; 1974 Nov; 92(32):1325-8. PubMed ID: 4457439 [No Abstract] [Full Text] [Related]
18. Ocimum sanctum Linn--a study on gastric ulceration and gastric secretion in rats. Mandal S; Das DN; De K; Ray K; Roy G; Chaudhuri SB; Sahana CC; Chowdhuri MK Indian J Physiol Pharmacol; 1993 Jan; 37(1):91-2. PubMed ID: 8449557 [TBL] [Abstract][Full Text] [Related]
19. [Pharmacological inhibition of gastric secretion and treatment of peptic ulcer]. Konturek SJ Rev Esp Enferm Apar Dig; 1978 Apr; 53(1):65-82. PubMed ID: 26940 [No Abstract] [Full Text] [Related]
20. Antisecretory effects of Librax in patients with duodenal ulcer. Head HB; Hammond JB Am J Dig Dis; 1968 Jun; 13(6):540-50. PubMed ID: 4879036 [No Abstract] [Full Text] [Related] [Next] [New Search]